Top

Published in:

01-01-2022 | Brain Tumor | Correction

Correction to: Epithelioid inflammatory myofibroblastic sarcoma with VCL–ALK fusion of central nervous system: case report and brief review of the literature

Authors: Shefali Chopra, Nolan Maloney, Wei Lien Wang

Published in: Brain Tumor Pathology | Issue 1/2022

Excerpt

In the original publication of the article, the copyright holder for this article was incorrectly given as “The Author(s), under exclusive licence to The Author(s) under exclusive licence to The Japan Society of Brain Tumor Pathology” but should have been “The Author(s) under exclusive licence to The Japan Society of Brain Tumor Pathology”. …

Title: Correction to: Epithelioid inflammatory myofibroblastic sarcoma with VCL–ALK fusion of central nervous system: case report and brief review of the literature
Authors: Shefali Chopra
Nolan Maloney
Wei Lien Wang
Publication date: 01-01-2022
Publisher: Springer Singapore
Keywords: Brain Tumor
Sarcoma
Pathology
Published in: Brain Tumor Pathology / Issue 1/2022
Print ISSN: 1433-7398
Electronic ISSN: 1861-387X
DOI: https://doi.org/10.1007/s10014-021-00425-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Correction to: Epithelioid inflammatory myofibroblastic sarcoma with VCL–ALK fusion of central nervous system: case report and brief review of the literature

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas

Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement

Molecular subtyping of ependymoma and prognostic impact of Ki-67

Epithelioid inflammatory myofibroblastic sarcoma with VCL–ALK fusion of central nervous system: case report and brief review of the literature